Deal Summary

Dyne Therapeutics

$400,000,000

Expanded debt facility

Hercules Capital

Deal Notes:

To prepare for the potential approval and commercial launches of z-rostudirsen and z-basivarsen

Industry:

Pharmaceuticals

Role:

Lender

Event:

Recapitalization

Recent Deal Announcements